VP2-T is a synthetic peptide comprising 39 amino acids. It is chemically engineered as a dual-acting agonist that targets both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. In laboratory research settings, VP2-T is a primary subject of investigation regarding the synergistic effects of simultaneous receptor activation on metabolic pathways.

Scientific literature suggests that VP2-T’s unique mechanism of action may play a significant role in the regulation of glucose metabolism, insulin sensitivity, and lipid utilization. It is frequently utilized in studies examining the physiological responses to incretin hormones and their potential influence on weight regulation and glycemic control markers in non-human models.